Not applicableStudy completedNCT00602134What this trial is testingBioequivalence Study of 6-Mercaptopurine Under Fasting ConditionsWho this might be right forAcute Lymphoblastic Leukemia Roxane Laboratories 54
Testing effectiveness (Phase 2)Study completedNCT00457964What this trial is testingRAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAMWho this might be right forTuberous SclerosisLymphangioleiomyomatosis Children's Hospital Medical Center, Cincinnati 36
Early research (Phase 1)Looking for participantsNCT06699771What this trial is testingPhase 1 to Investigate the Safety, Tolerability, and Efficacy of GCC2005 in Patients With R/R NK and T-cell MalignanciesWho this might be right forLymphoma, T-Cell GC Cell Corporation 53
Large-scale testing (Phase 3)Active Not RecruitingNCT03539744What this trial is testingA Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma.Who this might be right forMultiple Myeloma AbbVie 265
Not applicableLooking for participantsNCT02402244What this trial is testingProject: Every Child for Younger Patients With CancerWho this might be right forAdrenal Gland PheochromocytomaCarcinoma In SituCentral Nervous System Neoplasm+15 more Children's Oncology Group 75,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT03331198What this trial is testingStudy Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)Who this might be right forLeukemia, Lymphocytic, Chronic, B-CellLymphoma, Small Lymphocytic Juno Therapeutics, a Subsidiary of Celgene 320
Testing effectiveness (Phase 2)Ended earlyNCT01620216What this trial is testingTargeted Therapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous LeukemiaWho this might be right forAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeChronic Myelomonocytic LeukemiaRecurrent Acute Lymphoblastic Leukemia+3 more OHSU Knight Cancer Institute 12
Early research (Phase 1)Ended earlyNCT02998047What this trial is testingA Phase I Study of Lintuzumab-Ac225 in Patients With Refractory Multiple MyelomaWho this might be right forRefractory Multiple Myeloma Actinium Pharmaceuticals 2
Not applicableStudy completedNCT00100204What this trial is testingSalivary Proteins in Disease and HealthWho this might be right forDiabetes MellitusSarcoidosisDental Caries+3 more National Institute of Dental and Craniofacial Research (NIDCR) 264
Testing effectiveness (Phase 2)Study completedNCT00373906What this trial is testingVelcade in MALT Lymphoma PatientsWho this might be right forMALT Lymphoma Medical University of Vienna 16
Testing effectiveness (Phase 2)Study completedNCT01058434What this trial is testingSafety and Efficacy of TKI258 in Relapsed or Refractory Multiple Myeloma Patients, Who Are With or Without t(4;14) Chromosomal TranslocationWho this might be right forRelapsed or Refractory Multiple Myeloma Novartis Pharmaceuticals 43
Post-approval studies (Phase 4)Ended earlyNCT02618109What this trial is testingIdentification of New Immune Factors Specific of Relapse in Childhood B Lineage Acute Lymphoblastic LeukemiaWho this might be right forB Acute Lymphoblastic LeukemiaLeukemia Relapse University Hospital, Angers 119
Not applicableLooking for participantsNCT05737732What this trial is testingThe Ambient Light Multiple Myeloma StudyWho this might be right forMultiple Myeloma Icahn School of Medicine at Mount Sinai 200
Large-scale testing (Phase 3)Study completedNCT01724021What this trial is testingParticipant Preference With Subcutaneous Versus Intravenous MabThera/Rituxan in Participants With CD20+ Diffuse Large B-Cell Lymphoma or CD20+ Follicular Non-Hodgkin's Lymphoma Grades 1, 2 or 3aWho this might be right forDiffuse Large B-Cell Lymphoma, Non-Hodgkin's Lymphoma Hoffmann-La Roche 743
Early research (Phase 1)UnknownNCT00022906What this trial is testingSafety and Efficacy of Iodine-131 Anti-B1 Antibody for NHL Patients With Greater Than 25% Bone Marrow InvolvementWho this might be right forNon-Hodgkin's Lymphoma Corixa Corporation 24
Testing effectiveness (Phase 2)Looking for participantsNCT07520006What this trial is testingStudy of NX-5948 in Combination With Other Agents in Adults With B-cell MalignanciesWho this might be right forB-cell LymphomaChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Nurix Therapeutics, Inc. 150
Early research (Phase 1)Looking for participantsNCT06551584What this trial is testingTrial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCTWho this might be right forAcute Myeloid LeukemiaAcute Lymphoid LeukemiaMixed Phenotype Acute Leukemia+1 more Stanford University 24
Testing effectiveness (Phase 2)Study completedNCT02086552What this trial is testingSonidegib and Lenalidomide After Stem Cell Transplant in Treating Patients With Multiple MyelomaWho this might be right forRecurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma Mayo Clinic 28
Large-scale testing (Phase 3)Study completedNCT01358747What this trial is testingStudy of a Treatment Driven by Early PET Response to a Treatment Not Monitored by Early PET in Patients With AA Stage 3-4 or 2B HLWho this might be right forHodgkin's Lymphoma Centre Hospitalier Universitaire Dijon
Testing effectiveness (Phase 2)WithdrawnNCT01445587What this trial is testingGSK2110183 in Subjects With Proteasome Inhibitor Refractory Multiple MyelomaWho this might be right forCancer GlaxoSmithKline